封面
市場調查報告書
商品編碼
1602102

全球智慧注射器市場:按治療方法、應用和最終用戶分類 - 預測 2025-2030

Smart Syringes Market by Theraupetics (Active Safety Syringes, Auto-disable Syringes, Passive Safety Syringes), Application (Blood Specimen Collection, Drug Delivery, Vaccination), End User - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年智慧注射器市值為84.4億美元,預計2024年將達到104.6億美元,複合年成長率為24.61%,到2030年將達到393.8億美元。

智慧注射器是一種創新的醫療設備,旨在提高醫療環境的安全性和效率。與傳統注射器不同,智慧注射器配備自動停用、被動或主動安全機制等功能,旨在防止重複使用和針刺事故,並防止污染、愛滋病毒和肝炎等感染疾病的傳播。對智慧注射器的需求源於全球衛生政策提倡注射安全,以減少對醫護人員的Sharp Corporation傷害,從而導致整個醫療機構的需求增加。智慧注射器主要用於醫院、診所和門診手術中心,最終用途擴展到免疫計劃、治療注射和藥物傳輸系統等。智慧注射器市場的關鍵成長要素是對注射製劑的日益重視、需要重複安全給藥的慢性疾病數量的增加以及推動安全工程設備使用的嚴格要求。潛在的機會包括智慧技術的進步,例如支援物聯網的注射器,以提高對治療通訊協定的遵守率和用於有效庫存管理的 GPS 整合解決方案,以及增加醫療基礎設施投資的開拓中市場。然而,與傳統注射器相比成本較高、低收入地區認知度較低以及傳統醫療實踐變化帶來的阻力等挑戰可能會阻礙市場成長。創新技術包括具有成本效益的生產解決方案、智慧給藥和電子健康記錄整合以改善追蹤,以及開發環保材料以提高永續性。目前市場呈現出一個動態環境,其特點是技術快速進步、監管環境不斷變化以及醫療安全意識不斷增強,這使得想要保持競爭優勢並影響未來發展變得困難,對於想要回報的市場參與者來說,時機已經成熟。

主要市場統計
基準年[2023] 84.4億美元
預測年份 [2024] 104.6億美元
預測年份 [2030] 393.8億美元
複合年成長率(%) 24.61%

市場動態:揭示快速發展的智慧注射器市場的關鍵市場洞察

供需的動態交互作用正在改變智慧注射器市場。透過了解這些不斷變化的市場動態,公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 各種目標疾病盛行率上升和老年人口增加
    • 增加疫苗宣傳活動和舉措
    • 醫療相關感染和針刺傷的發生率增加
  • 市場限制因素
    • 智慧注射器產品召回
  • 市場機會
    • 對環境安全和自毀注射器的需求不斷成長
    • 對病人健康和安全的嚴格規定
  • 市場挑戰
    • 新興國家對智慧注射器的認知度和使用率較低

波特五力:駕馭智慧注射器市場的策略工具

波特的五力框架是了解智慧注射器市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢,解決弱點並避免潛在的挑戰,從而確保更強大的市場地位。

PESTLE分析:了解智慧注射器市場的外部影響

外部宏觀環境因素在塑造智慧注射器市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並幫助他們做出積極主動的決策。

市場佔有率分析 了解智慧注射器市場競爭狀況

對智慧注射器市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣智慧注射器市場廠商績效評估

FPNV定位矩陣是評估智慧注射器市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商,從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商,幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析:

1. 市場滲透率:對當前市場環境的詳細回顧,包括行業主要企業的大量資料。

2. 市場開拓:辨識新興市場的成長機會,評估現有領域的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,以幫助相關人員做出明智的決策:

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品、區隔市場和地區提供最佳投資機會?

3.塑造市場的主要技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 各種目標疾病的盛行率上升以及老年人口的增加
      • 加大疫苗宣傳活動和力度
      • 醫療機構感染案例增多,針刺事故增多
    • 抑制因素
      • 智慧注射器產品召回
    • 機會
      • 對環境安全且具有自動停用功能的注射器的需求不斷成長
      • 關於病人健康和安全的嚴格規定
    • 任務
      • 新興國家對智慧注射器的認知度和使用率較低
  • 市場區隔分析
    • 治療:在疫苗宣傳活動中增加使用自毀式注射器
    • 應用:智慧注射器在給藥方面的廣泛適用性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 智慧注射器市場:依治療方法

  • 主動安全注射器
  • 自動禁用注射器
  • 被動安全注射器

第7章智慧注射器市場:依應用分類

  • 血液檢體採集
  • 藥物輸送
  • 疫苗接種

第8章智慧注射器市場:依最終用戶分類

  • 診斷中心
  • 醫院和 HMO
  • 醫生診所

第9章 北美、南美智慧注射器市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太智慧注射器市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲智慧注射器市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
    • Terumo Corporation India 為需要每日注射胰島素的患者推出胰島素注射器
    • Sharp Corporation Technology 與 Nephron Pharmaceuticals 簽訂資產購買協議,收購 Inject EZ 特種共聚物注射器製造廠,並簽訂價值超過 4 億美元的 10 年期購買協議
    • Stevanato Group 與 Transcoject 合作,為製藥業提供預填充式注射器聚合物選擇

公司名單

  • Shanghai Kohope Medical Co., Ltd.
  • Hindustan Syringes & Medical Devices Ltd.
  • MHC Medical Products, LLC
  • Shimadzu Corporation
  • Biocorp by Novo Nordisk A/S
  • Sharps Technology, Inc.
  • Stevanato Group
  • Cardinal Health, Inc.
  • Owen Mumford Limited
  • Tecan Group Ltd.
  • B. Braun SE
  • Vogt Medical Vertrieb GmbH
  • Sol-Millennium Medical Group
  • AdvaCare Pharma
  • Agilent Technologies, Inc.
  • Baxter International Inc.
  • Gerresheimer AG
  • Numedico Technologies Pty Ltd.
  • Thermo Fisher Scientific Inc.
  • UltiMed, Inc.
  • Terumo Corporation
  • Revolutions Medical Corporation
  • Medtronic PLC
  • Retractable Technologies, Inc.
  • Parker-Hannifin Corporation
  • Becton, Dickinson and Company
  • DMC Medical Limited
  • Smiths Group PLC
Product Code: MRR-03050D1B2D40

The Smart Syringes Market was valued at USD 8.44 billion in 2023, expected to reach USD 10.46 billion in 2024, and is projected to grow at a CAGR of 24.61%, to USD 39.38 billion by 2030.

Smart syringes are innovative medical devices engineered to enhance safety and efficiency in medical practices. Unlike traditional syringes, smart syringes are equipped with features such as auto-disable, passive or active safety mechanisms designed to prevent re-use and needle stick injuries, addressing critical healthcare concerns such as contamination and the spread of infections like HIV and Hepatitis. The necessity for smart syringes arises from global health policies advocating for safety in injection practices to reduce sharps injuries among healthcare workers, subsequently driving their demand across healthcare settings. They are predominantly utilized in hospitals, clinics, and ambulatory surgical centers, with end-use extending particularly to immunization programs, therapeutic injections, and drug delivery systems. A major growth factor in the smart syringe market is the rising emphasis on injectable formulations, increasing incidences of chronic diseases necessitating repeated and safe medication delivery, coupled with stringent government regulations promoting the use of safety-engineered devices. Potential opportunities include advancements in smart technologies such as IoT-enabled syringes enhancing adherence to treatment protocols and GPS-integrated solutions for effective inventory management, alongside expanding markets in developing regions with growing healthcare infrastructure investments. However, challenges such as high costs compared to traditional syringes, limited awareness in low-income regions, and resistance due to changes in traditional medical practices may hinder market growth. Innovations could focus on cost-effective production solutions, integrating smart drug delivery with electronic health records for better tracking, and eco-friendly material development to enhance sustainability. The market currently exhibits a dynamic environment characterized by rapid technological advancements, shifting regulatory landscapes, and an increasing awareness of healthcare safety, making it ripe for strategic investments in R&D and partnerships with tech companies for market players aiming to maintain competitive advantage and influence future developments.

KEY MARKET STATISTICS
Base Year [2023] USD 8.44 billion
Estimated Year [2024] USD 10.46 billion
Forecast Year [2030] USD 39.38 billion
CAGR (%) 24.61%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Smart Syringes Market

The Smart Syringes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising Prevalence of Various Target Diseases and Growth of the Geriatic Population
    • Increasing Number of Vaccination Campaigns and Initiatives
    • Major incidents of Healthcare-Acquired Infections and Rise in Count of Needle Stick Injuries
  • Market Restraints
    • Smart Syringes Product Recalls
  • Market Opportunities
    • Growing Need for Environmentally Safe and Auto Disable Syringes
    • Stringent Regulation for Patient Health and Safety
  • Market Challenges
    • Low Awareness and Usage of Smart Syringes in Developing Countries

Porter's Five Forces: A Strategic Tool for Navigating the Smart Syringes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Smart Syringes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Smart Syringes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Smart Syringes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Smart Syringes Market

A detailed market share analysis in the Smart Syringes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Smart Syringes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Smart Syringes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Smart Syringes Market, highlighting leading vendors and their innovative profiles. These include Shanghai Kohope Medical Co., Ltd., Hindustan Syringes & Medical Devices Ltd., MHC Medical Products, LLC, Shimadzu Corporation, Biocorp by Novo Nordisk A/S, Sharps Technology, Inc., Stevanato Group, Cardinal Health, Inc., Owen Mumford Limited, Tecan Group Ltd., B. Braun SE, Vogt Medical Vertrieb GmbH, Sol-Millennium Medical Group, AdvaCare Pharma, Agilent Technologies, Inc., Baxter International Inc., Gerresheimer AG, Numedico Technologies Pty Ltd., Thermo Fisher Scientific Inc., UltiMed, Inc., Terumo Corporation, Revolutions Medical Corporation, Medtronic PLC, Retractable Technologies, Inc., Parker-Hannifin Corporation, Becton, Dickinson and Company, DMC Medical Limited, and Smiths Group PLC.

Market Segmentation & Coverage

This research report categorizes the Smart Syringes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Theraupetics, market is studied across Active Safety Syringes, Auto-disable Syringes, and Passive Safety Syringes.
  • Based on Application, market is studied across Blood Specimen Collection, Drug Delivery, and Vaccination.
  • Based on End User, market is studied across Diagnostics Center, Hospitals & HMOs, and Physician Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Prevalence of Various Target Diseases and Growth of the Geriatic Population
      • 5.1.1.2. Increasing Number of Vaccination Campaigns and Initiatives
      • 5.1.1.3. Major incidents of Healthcare-Acquired Infections and Rise in Count of Needle Stick Injuries
    • 5.1.2. Restraints
      • 5.1.2.1. Smart Syringes Product Recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing Need for Environmentally Safe and Auto Disable Syringes
      • 5.1.3.2. Stringent Regulation for Patient Health and Safety
    • 5.1.4. Challenges
      • 5.1.4.1. Low Awareness and Usage of Smart Syringes in Developing Countries
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Therapeutics: Increasing use of auto-disable syringes for immunization campaigns
    • 5.2.2. Application: Wide applicability of smart syringes for drug delivery
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Smart Syringes Market, by Theraupetics

  • 6.1. Introduction
  • 6.2. Active Safety Syringes
  • 6.3. Auto-disable Syringes
  • 6.4. Passive Safety Syringes

7. Smart Syringes Market, by Application

  • 7.1. Introduction
  • 7.2. Blood Specimen Collection
  • 7.3. Drug Delivery
  • 7.4. Vaccination

8. Smart Syringes Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostics Center
  • 8.3. Hospitals & HMOs
  • 8.4. Physician Clinics

9. Americas Smart Syringes Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Smart Syringes Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Smart Syringes Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Terumo India Introduces Insulin Syringe for Patients Requiring Daily Insulin Injections
    • 12.3.2. Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over USD 400 Million from Nephron Pharmaceuticals
    • 12.3.3. Stevanato Group Collaborates with Transcoject to Provide Pre-Fillable Syringe Polymer Options for Pharma

Companies Mentioned

  • 1. Shanghai Kohope Medical Co., Ltd.
  • 2. Hindustan Syringes & Medical Devices Ltd.
  • 3. MHC Medical Products, LLC
  • 4. Shimadzu Corporation
  • 5. Biocorp by Novo Nordisk A/S
  • 6. Sharps Technology, Inc.
  • 7. Stevanato Group
  • 8. Cardinal Health, Inc.
  • 9. Owen Mumford Limited
  • 10. Tecan Group Ltd.
  • 11. B. Braun SE
  • 12. Vogt Medical Vertrieb GmbH
  • 13. Sol-Millennium Medical Group
  • 14. AdvaCare Pharma
  • 15. Agilent Technologies, Inc.
  • 16. Baxter International Inc.
  • 17. Gerresheimer AG
  • 18. Numedico Technologies Pty Ltd.
  • 19. Thermo Fisher Scientific Inc.
  • 20. UltiMed, Inc.
  • 21. Terumo Corporation
  • 22. Revolutions Medical Corporation
  • 23. Medtronic PLC
  • 24. Retractable Technologies, Inc.
  • 25. Parker-Hannifin Corporation
  • 26. Becton, Dickinson and Company
  • 27. DMC Medical Limited
  • 28. Smiths Group PLC

LIST OF FIGURES

  • FIGURE 1. SMART SYRINGES MARKET RESEARCH PROCESS
  • FIGURE 2. SMART SYRINGES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SMART SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SMART SYRINGES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SMART SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SMART SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SMART SYRINGES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SMART SYRINGES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SMART SYRINGES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SMART SYRINGES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SMART SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SMART SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SMART SYRINGES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SMART SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SMART SYRINGES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SMART SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SMART SYRINGES MARKET DYNAMICS
  • TABLE 7. GLOBAL SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SMART SYRINGES MARKET SIZE, BY ACTIVE SAFETY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SMART SYRINGES MARKET SIZE, BY AUTO-DISABLE SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SMART SYRINGES MARKET SIZE, BY PASSIVE SAFETY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SMART SYRINGES MARKET SIZE, BY BLOOD SPECIMEN COLLECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SMART SYRINGES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SMART SYRINGES MARKET SIZE, BY VACCINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SMART SYRINGES MARKET SIZE, BY DIAGNOSTICS CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SMART SYRINGES MARKET SIZE, BY HOSPITALS & HMOS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SMART SYRINGES MARKET SIZE, BY PHYSICIAN CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS SMART SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES SMART SYRINGES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. SMART SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. SMART SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023